相关实验视频

Updated: May 24, 2025

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

用于治疗增殖性玻璃色素变异症的药理学药物:系统性审查和网络元分析

Sina Khosravi Mirzaei¹, Firouze Hatami¹, Sare Safi²

¹Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Ocular Tissue Engineering Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Survey of ophthalmology

|March 3, 2025

概括

13-cis-retinoic acid (13-cis-RA) 显著改善了视网膜重新连接和减少了视网膜脱落手术后的重新操作率. 大多数其他药理学药物在增殖性玻璃色素变异症 (PVR) 治疗中没有显著的益处.

科学领域:

眼科医生眼科眼科
药理学药理学是指药理学的学科.
基于证据的医学基于证据的医学

背景情况:

增殖性视网膜病变 (PVR) 是视网膜脱落 (RD) 手术后失败的主要原因.
有效的药理疗法来改善PVR的外科治疗结果仍然是一个未满足的临床需求.

研究的目的:

系统地审查和执行网络元分析 (NMA) 关于药理学药物的有效性PVR治疗后RD手术.
为了确定改善视网膜重新连接并降低PVR复发和重新手术率的药物.

主要方法:

在PubMed,Scopus,Web of Science和Embase进行了全面的系统搜索.
包括随机对照试验,非随机对照试验和比较观察性研究.
网络对视网膜重新连接,PVR复发和重新手术率的元分析.

主要成果:

辅助的13-cis-retinoic acid (13-cis-RA) 显著改善了视网膜的重新连接 (RR=1.36) 和降低了重新操作率 (RR=0.23).
没有其他被评估的药物在初级或二级结局上显示出统计学上显著的改善.
在一项研究中,德克萨米他显示出对黄斑的潜在降低;其他药物没有显著影响IOP,ERM或黄斑.

结论:

大多数药理学药物在RD手术后不会显著改善PVR的结果.
13-cis-RA是唯一一种药物,它对视网膜重新连接和重新手术率产生了显著的积极影响.
需要进一步进行高质量的临床试验来验证这些发现,并探索最佳的PVR药物治疗.

关键词:

皮质上皮膜的皮质上皮膜膜.眼内压力眼内压力网络元分析网络元分析增殖性玻璃乙烯基红蛋白变异性视网膜脱落视网膜脱落

更多相关视频

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...